CLINICAL_TRIALS
trial_result
· 2010-11-03
Clinical Trial Update: Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease [Phase 2]
Summary
Phase 2 clinical trial update shows termination of a study evaluating the metabolic effects of thiazolidinediones in chronic kidney disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Vanderbilt University | Conditions: Chronic Kidney Disease | Phase 2 | Status: TERMINATED